Topiramate
Product Images NDC 50436-9952

3 FDA label images from Unit Dose Services · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 50436-9952). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unit Dose Services, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical-structure (Chemical Structure)

Chemical-structure (Chemical Structure)
Chemical structure of Topiramate, showing its ring system with multiple oxygen atoms and attached functional groups including methanesulfonamide and methyl groups.*
FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
Kaplan-Meier plot showing cumulative rates for time to first seizure over 500 days for Topiramate at doses of 50 mg/day and 400 mg/day. The y-axis represents cumulative rates for time to first seizure, while the x-axis shows time in days. Two curves are presented: a solid line for 50 mg/day (N=234) and a dotted line for 400 mg/day (N=236). A p-value of 0.0002 is indicated on the graph.*
FDA Label Image

Label Image (Lbl504369952)

Label Image (Lbl504369952)
Topiramate 200 mg tablet bottle label by Unit Dose Services, containing 60 tablets. The label includes the NDC code 50436-9952-2, manufacturer listed as CARACO, and storage instructions to keep out of reach of children and store at 20-25°C. Additional identifiers include another NDC, 62756-0712-13, and barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.